Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
01/04/2012 | EP2401276A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
01/04/2012 | EP2401275A1 Novel bronchodilating diazaheteroaryls |
01/04/2012 | EP2401274A1 Imidazo [1, 2 -a]pyridines as jnk modulators |
01/04/2012 | EP2401269A1 Indole derivatives as crth2 receptor antagonists |
01/04/2012 | EP2401262A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
01/04/2012 | EP2400848A1 Crystalization of pharmaceutical compounds |
01/04/2012 | EP2400844A1 Stereoselective hydrogenation of a ketone |
01/04/2012 | EP2310389B1 Heterocycles as protein kinase inhibitors |
01/04/2012 | EP2297148B1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
01/04/2012 | EP2146989B1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
01/04/2012 | EP1986645B1 Glucokinase activators |
01/04/2012 | EP1928461B1 Pyrimidine compounds as serotonin receptor modulators |
01/04/2012 | EP1833827B9 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
01/04/2012 | CN102307874A Peripheral opioid receptor antagonists and uses thereof |
01/04/2012 | CN102307870A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease |
01/04/2012 | CN102307867A Dihydroquinolinone derivatives |
01/04/2012 | CN102304128A Heterocyclic naphthalimide derivative as well as preparation method and application thereof |
01/04/2012 | CN102304127A Novel method for preparing tenatoprazole |
01/04/2012 | CN102304126A New process for extracting and purifying Swainsonine from plants |
01/04/2012 | CN101918039B Use of novel compound having affinity for amyloid, and process for production of the same |
01/04/2012 | CN101735216B Europium complex silicon dioxide fluorescent nano particles and preparation method thereof |
01/04/2012 | CN101248078B Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
01/03/2012 | US8088924 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
01/03/2012 | US8088923 Cyclic-fused beta-lactones and their synthesis |
01/03/2012 | US8088792 Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors |
01/03/2012 | US8088790 Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods |
01/03/2012 | US8088788 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods |
01/03/2012 | US8088765 Polysubstituted derivatives of 6-heteroarylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof |
01/03/2012 | US8088761 Enzyme inhibitors |
01/03/2012 | CA2662148C Phthalazine, aza- and diaza-phthalazine compounds and medicinal uses thereof |
01/03/2012 | CA2636077C Thiazole compounds as protein kinase b (pkb) inhibitors |
01/03/2012 | CA2632194C N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
01/03/2012 | CA2622639C Hiv integrase inhibitors |
01/03/2012 | CA2558245C An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides |
01/03/2012 | CA2524525C Novel pyridopyrazines and use thereof as kinase modulators |
01/03/2012 | CA2491216C Method of producing a cationic liposomal preparation comprising a lipophilic compound |
01/03/2012 | CA2481321C [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
01/03/2012 | CA2397661C 2,4-disubstituted thiazolyl derivatives |
12/29/2011 | WO2011163610A2 Antimicrobial agents |
12/29/2011 | WO2011163355A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
12/29/2011 | WO2011162300A1 Crystal of fused pyridine compound salt |
12/29/2011 | WO2011162162A1 Light-emitting device material and light-emitting device |
12/29/2011 | WO2011161256A1 Beta carboline derivatives useful in the treatment of proliferative disorders |
12/29/2011 | WO2011161159A1 Heterocyclic compounds, their preparation and their therapeutic application |
12/29/2011 | WO2011161008A1 Quinolizidine and indolizidine derivatives |
12/29/2011 | WO2011160548A1 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and use thereof |
12/29/2011 | US20110319619 Novel 1,6-disubstituted-3-amino-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridin-7-one compounds and preparation thereof |
12/29/2011 | US20110319443 Inhibitors of akt activity |
12/29/2011 | US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds |
12/29/2011 | US20110319424 Naphthyridin-2(1h) -one compounds useful as antibacterials |
12/29/2011 | US20110319409 7-aza-quinazoline pde10 inhibitors |
12/29/2011 | US20110319406 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
12/29/2011 | US20110319400 Prokineticin 1 receptor antagonists for the treatment of pain |
12/29/2011 | US20110319394 Fused heterocyclic compounds |
12/29/2011 | US20110319378 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
12/29/2011 | US20110318842 Systems for the light-induced separation of charges |
12/29/2011 | US20110318345 Nasal delivery |
12/29/2011 | US20110317102 Lyotropic liquid crystal systems based on aromatic tetracarboxylic bisbenzoimidazole derivatives and methods for making |
12/29/2011 | US20110315933 Materials for organic electroluminescent devices |
12/29/2011 | CA2803890A1 Antimicrobial agents |
12/29/2011 | CA2803697A1 Beta carboline derivatives useful in the treatment of proliferative disorders |
12/29/2011 | CA2803496A1 Heterocyclic compounds, their preparation and their therapeutic application |
12/29/2011 | CA2803156A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
12/29/2011 | CA2802733A1 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
12/29/2011 | CA2797874A1 Quinolizidine and indolizidine derivatives |
12/28/2011 | EP2399918A1 Ring compound |
12/28/2011 | EP2398801A1 3, 3' -spiroindolinone derivatives as anticancer agents |
12/28/2011 | EP2398800A1 Pyrimidin-4(3h)-one derivatives |
12/28/2011 | EP2398799A2 Pyridocarbazole type compounds and applications thereof |
12/28/2011 | EP2398798A1 Triazolopyridine derivatives as p38 map kinase inhibitors |
12/28/2011 | EP2398797A1 Pyrimido [5,4-d]pyrimidine derivatives for the inhibition of tyrosine kinases |
12/28/2011 | EP2398793A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators |
12/28/2011 | EP2398790A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
12/28/2011 | EP2225202B1 Preparation of dihydropyrrol derivatives as intermediates |
12/28/2011 | EP2178858B1 Novel heterocyclic compounds as mglu5 antagonists |
12/28/2011 | EP2173721B1 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
12/28/2011 | EP1981871B1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
12/28/2011 | EP1664036B1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
12/28/2011 | CN102300862A 用作atr激酶抑制剂的化合物 Compounds useful as kinase inhibitors atr |
12/28/2011 | CN102300860A 作为磷酸二酯酶10抑制剂的吡嗪类化合物 As a phosphodiesterase inhibitor compound 10 pyrazines |
12/28/2011 | CN102300846A 用于标记正电子发射同位素的三芳基锍化合物、药盒和方法 For labeling n triaryl sulfonium compounds, kits and methods of the electron-emitting isotopes |
12/28/2011 | CN102300574A 新的吲哚基-*二唑基-二氮杂二环壬烷衍生物及它们的医药和诊断用途 New indolyl - * oxadiazolyl - diaza-bicyclo-nonane derivatives and their pharmaceutical and diagnostic purposes |
12/28/2011 | CN102295645A 8-苄基-2,8-二氮杂双环[4.3.0]壬烷的合成方法 8-benzyl-2,8-diazabicyclo [4.3.0] nonane synthetic methods |
12/28/2011 | CN102295644A 一种合成1-卤-2-芳基中氮茚类化合物的方法 A synthetic 1- halo-2-aryl indolizine compound Method |
12/28/2011 | CN102295643A 2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮 2- (pyridin-2-ylamino) - pyrido [2,3-d] pyrimidin-7-one |
12/28/2011 | CN102295642A 2-芳基咪唑并[1,2-a]吡啶-3-乙酰胺衍生物、其制备方法及用途 2-aryl-imidazo [1,2-a] pyridine-3-acetamide derivatives, their preparation and use |
12/28/2011 | CN102295637A 5-lipoxygenase-activating protein (FLAP) inhibitors |
12/28/2011 | CN102295634A 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途 The new hydroxy-6-heteroaryl phenanthrene piperidine and its use as an inhibitor pde4 |
12/28/2011 | CN102293773A 含有苯并硫氮杂卓和苯并虑平化合物的药物 Benzothiazepine and benzo drugs containing compounds doxepin |
12/28/2011 | CN101679306B 治疗神经变性疾病的杂芳基酰胺取代的嘧啶酮衍生物 Treatment of neurodegenerative diseases heteroaryl amide substituted pyrimidone derivatives |
12/28/2011 | CN101312973B 新的中氮茚衍生物,它们的制备方法和含有它们的药物组合物 New indolizine derivatives, processes for their preparation and pharmaceutical compositions containing them |
12/27/2011 | US8084937 Binaphthyl compound and organic light emitting element using the same |
12/27/2011 | US8084603 Naphthalenetetracarboxylic acid derivatives and their use as semiconductors |
12/27/2011 | US8084462 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
12/27/2011 | US8084459 Substituted quinazolinones for treating neurological conditions |
12/27/2011 | US8084450 Organic compounds |
12/22/2011 | WO2011160084A1 D2 antagonists, methods of synthesis and methods of use |
12/22/2011 | WO2011159917A2 Growth hormone secretatogue receptor antagonists and uses thereof |
12/22/2011 | WO2011159854A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
12/22/2011 | WO2011159657A1 Bicyclic heterocycle derivatives and methods of use thereof |